Showing results (1011-1020 of 1,104) with videos related to
Sort By:
Pageof 111
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.Cancer Discovery|April 14, 2022
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive CholangiocarcinomaQibiao Wu, Yuanli Zhen, Lei Shi, et al.Blood|January 26, 2010
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationWen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, et al.Haematologica|April 17, 2025
A phase I / IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosisPankit Vachhani, Peter Tan, Anne-Marie Watson, et al.Blood|April 15, 2025
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapyNaval G Daver, Paresh Vyas, Gerwin A Huls, et al.Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 5, 2023
A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter studyChang-Yue Zheng, Ju Wu, Chun-Sen Chen, et al.Pageof 111